Anna Pettersen

发表

Discovery of AZD6642, an inhibitor of 5-lipoxygenase activating protein (FLAP) for the treatment of inflammatory diseases.

Susanne Winiwarter, Johan Ulander, Anna Pettersen, 2015, Journal of medicinal chemistry.

Structural origin of physicochemical properties differences upon dehydration and polymorphic transformation of ciprofloxacin hydrochloride revealed by structure determination from powder X-ray diffraction data

E. Yonemochi, H. Uekusa, Anna Pettersen, 2020 .

A peculiar dehydration and solid–solid phase transition of the active pharmaceutical ingredient AZD9898 based on in situ single crystal-to-single crystal transformations

M. Light, Anna Pettersen, O. Putra, 2020 .

Capturing a new hydrate polymorph of amodiaquine dihydrochloride dihydrate via heterogeneous crystallisation

Yuda Prasetya Nugraha, E. Yonemochi, H. Uekusa, 2019, CrystEngComm.

Elucidating an Amorphous Form Stabilization Mechanism for Tenapanor Hydrochloride: Crystal Structure Analysis Using X-ray Diffraction, NMR Crystallography, and Molecular Modeling.

Sten O. Nilsson Lill, K. Shankland, L. Emsley, 2018, Molecular pharmaceutics.

Potassium channel blocking 1,2-bis(aryl)ethane-1,2-diamines active as antiarrhythmic agents.

L. Carlsson, T. Inghardt, Anna Pettersen, 2019, Bioorganic & medicinal chemistry letters.

Discovery of AZD4831, a Mechanism-Based Irreversible Inhibitor of Myeloperoxidase, As a Potential Treatment for Heart Failure with Preserved Ejection Fraction

E. Michaëlsson, B. Kull, T. Sjögren, 2022, Journal of medicinal chemistry.

1 Discovery of AZD4831, a Mechanism-Based Irreversible Inhibitor of 2 Myeloperoxidase, As a Potential Treatment for Heart Failure with 3 Preserved Ejection Fraction

B. Kull, E. Lindstedt, T. Inghardt, 2022 .

Saccharin Aza Bioisosteres-Synthesis and Preclinical Property Comparisons.

R. Lewis, M. A. Hayes, M. Lepistö, 2017, ACS medicinal chemistry letters.

Synthesis of Sulfonimidamide-Based Amino Acid Building Blocks with Orthogonal Protecting Groups

P. Arvidsson, A. Sandström, Anna Pettersen, 2019, European Journal of Organic Chemistry.

Mechanochemical preparation of molecular and supramolecular organometallic materials and coordination networks.

D. Braga, F. Grepioni, M. Polito, 2006, Dalton transactions.

Novel potent and efficacious nonpeptidic urotensin II receptor agonists.

U. Hacksell, K. Luthman, E. Currier, 2006, Journal of medicinal chemistry.

Synthesis of secondary amines by reductive dimerization of azides

Anna Pettersen, K. Undheim, M. Lange, 1998 .

Toward the Design of Molecular Chameleons: Flexible Shielding of an Amide Bond Enhances Macrocycle Cell Permeability.

Vasanthanathan Poongavanam, J. Kihlberg, M. Tyagi, 2018, Organic letters.

Does Z' equal 1 or 2? Enhanced powder NMR crystallography verification of a disordered room temperature crystal structure of a p38 inhibitor for chronic obstructive pulmonary disease.

Sten O. Nilsson Lill, L. Emsley, S. N. Nilsson Lill, 2017, Physical chemistry chemical physics : PCCP.

Understanding Crystal Structures to Guide Form Selection of Active Pharmaceutical Ingredients: A Case Study of AZD9567

S. N. Nilsson Lill, Anna Pettersen, O. Putra, 2021, Crystal Growth & Design.

Discovery of the Oral Leukotriene-C4 Synthetase Inhibitor (1S,2S)-2-({5-[(5-Chloro-2,4-difluorophenyl)(2-fluoro-2-methylpropyl)amino]-3-methoxypyrazin-2-yl}carbonyl)cyclopropanecarboxylic acid (AZD9898) as a New Treatment for Asthma.

L. Swedin, U. Andersson, C. Tyrchan, 2019, Journal of medicinal chemistry.

Utilizing Crystal Structures for Predicting Impact of Mechanical and Surface Properties on Particle Fracture

Sten O. Nilsson Lill, M. Fransson, C. Boissier, 2019, Crystal Growth & Design.

Cediranib Maleate - from crystal structure towards materials control.

S. Black, Helen P. Wheatcroft, Anna Pettersen, 2019, Journal of pharmaceutical sciences.

Discovery of (3-(4-(2-Oxa-6-azaspiro[3.3]heptan-6-ylmethyl)phenoxy)azetidin-1-yl)(5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl)methanone (AZD1979), a Melanin Concentrating Hormone Receptor 1 (MCHr1) Antagonist with Favorable Physicochemical Properties.

P. Gennemark, L. Benthem, A. Hogner, 2016, Journal of medicinal chemistry.